Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene

This publication has 14 references indexed in Scilit:

• Expression of NAG-1, a Transforming Growth Factor-β Superfamily Member, by Troglitazone Requires the Early Growth Response Gene EGR-1
  Journal of Biological Chemistry, 2004
• RETRACTED: Molecular based treatment of oral cancer
  Oral Oncology, 2003
• Nonsteroidal anti‐inflammatory drug‐activated gene (NAG‐1) is induced by genistein through the expression of p53 in colorectal cancer cells
  International Journal of Cancer, 2003
• Differential Regulation of Nonsteroidal Anti-Inflammatory Drug-Activated Gene in Normal Human Tracheobronchial Epithelial and Lung Carcinoma Cells by Retinoids
  Molecular Pharmacology, 2003
• Oral cavity and pharynx cancer incidence rates in the United States, 1975–1998 ☆ ☆Portions of this manuscript were presented at the meeting of the American Association of Public Health Dentistry in October 1999.
  Oral Oncology, 2002
• PTGF-β , a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway
  Proceedings of the National Academy of Sciences, 2000
• Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
  Biochemical Pharmacology, 1996
• Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and Apoptosis
  Experimental Cell Research, 1996
• Differential effects of retinoic acid on the in vitro growth and cell‐surface glycoconjugates of 2 human head and neck squamous‐cell carcinomas
  International Journal of Cancer, 1987
• Transient expression of genes introduced into cultured cells of Drosophila.
  Proceedings of the National Academy of Sciences, 1983